Advertise on podcast: The Carlat Psychiatry Podcast

Today, we will be discussing the challenges of managing antipsychotic medications in children and adolescents. We will explore various strategies that aim to balance symptom relief with potential side effects, while also guiding towards personalized and safer treatment options. Join us in discovering the art of precision in pediatric mental health care.Published On: 02/26/2024Duration: 19minutes, 25 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Here's a Throwback Thursday episode originally cast in March of 2021, where we're going to look at the question of whether adding a z hypnotic improves antidepressant response. And stay tuned to the very end where I'm going to update it with new research. We all know that when you sleep better, you feel better.CME: Take the CME Post-Test for this EpisodePublished On: 02/22/2024Duration: 27 minutes, 56 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dosing is not a collaborative venture when it comes to controlled substances, and here we look for the safe upper limits of stimulant dosing.CME: Take the CME Post-Test for this Episode (https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/4623-stimulant-dosing)Published On: 02/19/2024Duration: 22 minutes, 23 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants, benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case.Today, in part one of a two-part series, we'll open up a forgotten repository of psychiatric research, where a stack of about 50 controlled trials has been archived away, suggesting that the GABAergic benzos might actually treat depression.CME: Take the CME Post-Test for this EpisodePublished On: 02/15/2024Duration: 27 minutes, 43 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.CME: Take the CME Post-Test for this EpisodePublished On: 02/12/2024Duration: 16 minutes, 44 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depressionCME: Take the CME Post-Test for this EpisodePublished On: 02/05/2024Duration: 14 minutes, 02 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to choose a mood stabilizer in older adults.CME: Take the CME Post-Test for this EpisodePublished On: 01/29/2024Duration: 17 minutes, 40 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Bipolar disorder is different in the elderly. Today we look at the medical causes to watch out for.CME: Take the CME Post-Test for this Episode (https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/4605-bipolar-in-older-adults)Published On: 01/22/2024Duration: 12 minutes, 19 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Have you ever wondered about using Deep Brain Stimulation, DBS, for kids dealing with Obsessive Compulsive Disorder, OCD? It's a hot topic among parents, but do we have enough evidence to back up this rather intense treatment? Let's dive in and take a closer look at deep brain stimulation.Published On: 01/14/2024Duration: 11minutes, 49 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We interview Stephan Jackman, whose company is developing a new formulation of lithium, and bring updates on lithium in younger, older, and peripartum patients.CME: Take the CME Post-Test for this EpisodePublished On: 01/08/2024Duration: 16 minutes, 44 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A year of research on lithium, including updates on its efficacy, renal risks, tremor, and a controlled trial of instant vs. extended releaseCME: Take the CME Post-Test for this EpisodePublished On: 01/01/2024Duration: 22 minutes, 06 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In today’s podcast, we explore background knowledge, experiences, andmisconceptions surrounding psychodynamic therapy and discuss how we define evidence for it with our guest, Dr. Jonathan Shedler.Published On: 12/25/2023Duration: 52 minutes, 47 secondsMark L. Ruffalo, MSW, DPsa, Jonathan Shedler, PhD, and Geneva Valeska, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.